beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells

Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L (2000)
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10(7): 677-680.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Schaschke, NorbertUniBi; Assfalg-Machleidt, I; Machleidt, W; Lassleben, T; Sommerhoff, CP; Moroder, L
Einrichtung
Fakultät für Chemie > Organische Chemie III
Erscheinungsjahr
2000
Zeitschriftentitel
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Band
10
Ausgabe
7
Seite(n)
677-680
ISSN
0960-894X
Page URI
https://pub.uni-bielefeld.de/record/2403852

Zitieren

Schaschke N, Assfalg-Machleidt I, Machleidt W, Lassleben T, Sommerhoff CP, Moroder L. beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 2000;10(7):677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C. P., & Moroder, L. (2000). beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 10(7), 677-680. https://doi.org/10.1016/S0960-894X(00)00078-0
Schaschke, Norbert, Assfalg-Machleidt, I, Machleidt, W, Lassleben, T, Sommerhoff, CP, and Moroder, L. 2000. “beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells”. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10 (7): 677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C. P., and Moroder, L. (2000). beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10, 677-680.
Schaschke, N., et al., 2000. beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 10(7), p 677-680.
N. Schaschke, et al., “beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells”, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 10, 2000, pp. 677-680.
Schaschke, N., Assfalg-Machleidt, I., Machleidt, W., Lassleben, T., Sommerhoff, C.P., Moroder, L.: beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 10, 677-680 (2000).
Schaschke, Norbert, Assfalg-Machleidt, I, Machleidt, W, Lassleben, T, Sommerhoff, CP, and Moroder, L. “beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells”. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 10.7 (2000): 677-680.

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Highly Functionalized β-Cyclodextrins by Solid-Supported Synthesis.
Vurgun N, Nitz M., Chemistry 24(17), 2018
PMID: 29389050
On the synthesis of cyclodextrin-peptide conjugates by the Huisgen reaction.
Lartia R, Jankowski CK, Arseneau S., J Pept Sci 22(8), 2016
PMID: 27443976
Cyclodextrin-peptide conjugates for sequence specific DNA binding.
Ruiz García Y, Zelenka J, Pabon YV, Iyer A, Buděšínský M, Kraus T, Smith CI, Madder A., Org Biomol Chem 13(18), 2015
PMID: 25857557
New glycoside derivatives of carnosine and analogs resistant to carnosinase hydrolysis: synthesis and characterization of their copper(II) complexes.
Lanza V, Bellia F, D'Agata R, Grasso G, Rizzarelli E, Vecchio G., J Inorg Biochem 105(2), 2011
PMID: 21194616
Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens.
Kim HY, Sohn J, Wijewickrama GT, Edirisinghe P, Gherezghiher T, Hemachandra M, Lu PY, Chandrasena RE, Molloy ME, Tonetti DA, Thatcher GR., Bioorg Med Chem 18(2), 2010
PMID: 20031420
Synthesis and pharmacological evaluation of a new targeted drug carrier system: beta-cyclodextrin coupled to oxytocin.
Bertolla C, Rolin S, Evrard B, Pochet L, Masereel B., Bioorg Med Chem Lett 18(6), 2008
PMID: 18296049
Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.
Béni S, Szakács Z, Csernák O, Barcza L, Noszál B., Eur J Pharm Sci 30(2), 2007
PMID: 17145172
Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update covering the period 1999-2000.
Harvey DJ., Mass Spectrom Rev 25(4), 2006
PMID: 16642463
Solid-phase synthesis of double-headed epoxysuccinyl activity-based probes for selective targeting of papain family cysteine proteases.
Verhelst SH, Bogyo M., Chembiochem 6(5), 2005
PMID: 15776409
Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.
Stern I, Schaschke N, Moroder L, Turk D., Biochem J 381(pt 2), 2004
PMID: 15084146
1,2,4-thiadiazole: a novel Cathepsin B inhibitor.
Leung-Toung R, Wodzinska J, Li W, Lowrie J, Kukreja R, Desilets D, Karimian K, Tam TF., Bioorg Med Chem 11(24), 2003
PMID: 14642597
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
Schaschke N, Deluca D, Assfalg-Machleidt I, Höhneke C, Sommerhoff CP, Machleidt W., Biol Chem 383(5), 2002
PMID: 12108551
Bivalent inhibition of human beta-tryptase.
Schaschke N, Matschiner G, Zettl F, Marquardt U, Bergner A, Bode W, Sommerhoff CP, Moroder L., Chem Biol 8(4), 2001
PMID: 11325588
Epoxysuccinyl peptide-derived affinity labels for cathepsin B.
Schaschke N, Assfalg-Machleidt I, Lassleben T, Sommerhoff CP, Moroder L, Machleidt W., FEBS Lett 482(1-2), 2000
PMID: 11018529

19 References

Daten bereitgestellt von Europe PubMed Central.

Cathepsin B and cystatins: evidence for a role in cancer progression.
Sloane BF., Semin. Cancer Biol. 1(2), 1990
PMID: 2103490

Elliott, Perspect. Drug Discov. Design 6(), 1996
Tumor protease-activated, pore-forming toxins from a combinatorial library.
Panchal RG, Cusack E, Cheley S, Bayley H., Nat. Biotechnol. 14(7), 1996
PMID: 9631009
Cyclodextrin derivatives in pharmaceutics.
Albers E, Muller BW., Crit Rev Ther Drug Carrier Syst 12(4), 1995
PMID: 9501966

Djedaı̈ni-Pilard, Tetrahedron Lett. 34(), 1993

Hristova-Kazmierski, Bioorg. Med. Chem. Lett. 3(), 1993

Schaschke, J. Am. Chem. Soc. 120(), 1998
Recognition ability and cytotoxicity of some oligosaccharidyl substituted beta-cyclodextrins.
Attioui F, al-Omar A, Leray E, Parrot-Lopez H, Finance C, Bonaly R., Biol. Cell 82(2-3), 1994
PMID: 7606211
Cyclodextrins as templates for the presentation of protease inhibitors.
Schaschke N, Musiol HJ, Assfalg-Machleidt I, Machleidt W, Rudolph-Bohner S, Moroder L., FEBS Lett. 391(3), 1996
PMID: 8764993
Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Moroder L., FEBS Lett. 421(1), 1998
PMID: 9462845
The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.
Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N., EMBO J. 10(9), 1991
PMID: 1868826

Coste, Tetrahedron Lett. 31(), 1990

AUTHOR UNKNOWN, 0

Singh, Pharm. Sci. 3(), 1997

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

Fujishima, FEBS Lett. 407(), 1997

AUTHOR UNKNOWN, 0
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 10762052
PubMed | Europe PMC

Suchen in

Google Scholar